Isocitrate Dehydrogenase 2 Inhibitor [EPC] - N0000193615

Pharmacologic Code	N0000193615
Pharmacologic Name	Isocitrate Dehydrogenase 2 Inhibitor
Pharmacologic Uses	isocitrate dehydrogenase-2 inhibitor
Pharmacologic Concept	Established Pharmacologic Classes - [EPC]
Pharmacologic Concept Description	An established pharmacologic class is a term or phrase that is scientifically valid and clinically meaningful according to the following definitions: A scientifically valid pharmacologic class is supported by documented and submitted empiric evidence showing that the drug's pharmacologic class is known, not theoretical, and relevant and specific to the indication. A clinically meaningful pharmacologic class term or phrase enhances the ability of professionals to understand physiologic effects related to the indication or to anticipate undesirable effects that may be associated with the drug or pharmacologic class.

The table contains 2 products whose active ingredient are classified under the same pharmacologic class Isocitrate Dehydrogenase 2 Inhibitor [EPC].

	NDC	Proprietary Name	Non-Proprietary Name	Dosage Form	Route Name	Company Name	Status
	59572-705	Idhifa	Non-Proprietary Name: Enasidenib Mesylate	Tablet, Film Coated	Oral	Celgene Corporation	ACTIVE
	59572-710	Idhifa	Non-Proprietary Name: Enasidenib Mesylate	Tablet, Film Coated	Oral	Celgene Corporation	ACTIVE